Page last updated: 2024-08-26

4-hydroxycyclophosphamide and Acute Myelogenous Leukemia

4-hydroxycyclophosphamide has been researched along with Acute Myelogenous Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clarkson, BD; Gasparetto, C; Gulati, SC; Lemoli, RM; Moore, MA; Scheinberg, DA1

Trials

1 trial(s) available for 4-hydroxycyclophosphamide and Acute Myelogenous Leukemia

ArticleYear
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.
    Blood, 1991, Apr-15, Volume: 77, Issue:8

    Topics: Adult; Aged; Antibodies, Monoclonal; Bone Marrow Transplantation; Cell Line; Colony-Forming Units Assay; Cyclophosphamide; Cytotoxicity, Immunologic; Etoposide; Female; Hematopoietic Stem Cells; Humans; Immunosuppression Therapy; Interleukin-1; Interleukin-3; Leukemia, Myeloid, Acute; Male; Middle Aged; Transplantation, Autologous

1991